Chipotle: Get Real

Summary

  • Chipotle continues to disappoint on growth initiatives to rebound from the 2015 health scare.
  • The expectation for a Q4 EPS dip is a big negative to the growth story.
  • The stock continues to trade at a stretched valuation in comparison to peers with '19 targets requiring a return to sizable contribution margins.

One of the biggest mistakes the market continues making with Chipotle Mexican Grill (NYSE:CMG) is the expectation that the restaurant concept will return to AUVs and margin levels prior to the October 2015 health scare. The data points continue to support that Chipotle is already producing new normalized levels questioning the high multiples placed on the stock following the new CEO rally.

Chipotle For Real logoImage Source: Chipotle website

New Normal

For Q3, Chipotle reported that net income and EPS soared over 60% from the prior period. Both numbers sound impressive, but the key here is that the restaurant concept is still returning to normalized levels following the 2015 health scare.

Chipotle reported a 4.4% comp sales gain, but the number fell below the 5.0% analyst estimates. Again, the key here is that the company should have been able to produce higher comps off the 2016 lows. The AUVs for the quarter were $1,980 million, down from the 2015 peak of $2,532 million. The company is still only slightly bouncing off the Q3'16 lows of $1,914.

Wells Fargo (WFC) echoed this concern suggesting that new competition makes it impossible for Chipotle to recapture its past glory. The Wells Fargo team lowered 2019 EPS estimates to only $11.45.

The big reason that Chipotle launched from $250-lows prior to the February hiring of Brian Niccol as the CEO to the $500-highs in August is that his leadership would allow the company to return to those $2.5 million unit volumes and mid-20% restaurant level margins. The combination had analysts pushing 2020 EPS estimates all the way above $15 now, with expectations of a further jump to $20.

The crucial restaurant operating margin reached 27.9% in Q3'15 right before the health scare. The latest quarter saw margins slip back to only 18.7%. The number was impressively off the 2016 and

This article was written by

52.96K Followers

Stone Fox Capital is an RIA from Oklahoma. Mark Holder is a CPA with degrees in Accounting and Finance. He is also Series 65 licensed and has 30 years of investing experience, including 15 years as a portfolio manager.

Mark leads the investing group

Out Fox The Street

where he shares stock picks and deep research to help readers uncover potential multibaggers while managing portfolio risk via diversification. Features include various model portfolios, stock picks with identifiable catalysts, daily updates, real-time alerts, and access to community chat and direct chat with Mark for questions.

Learn more

.

Analyst’s Disclosure:I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About CMG Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on CMG

Related Stocks

SymbolLast Price% Chg
CMG
--